{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:28:33Z","timestamp":1790800113253,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.biopha.2026.119528","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T07:21:20Z","timestamp":1779520880000},"page":"119528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Repurposing monepantel in oncology: A conceptual mini-review of proposed mechanisms"],"prefix":"10.1016","volume":"200","author":[{"given":"Safura","family":"Pournajaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Pourgholami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-8521","authenticated-orcid":false,"given":"David Lawson","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2026.119528_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00436-009-1636-1","article-title":"A pooled analysis of the efficacy of monepantel, an amino-acetonitrile derivative against gastrointestinal nematodes of sheep","volume":"106","author":"Hosking","year":"2010","journal-title":"Parasitol. Res"},{"issue":"4","key":"10.1016\/j.biopha.2026.119528_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00436-008-1080-7","article-title":"Identification of the amino-acetonitrile derivative monepantel (AAD 1566) as a new anthelmintic drug development candidate","volume":"103","author":"Kaminsky","year":"2008","journal-title":"Parasitol. Res"},{"issue":"8","key":"10.1016\/j.biopha.2026.119528_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijpara.2023.02.001","article-title":"Monepantel-based anthelmintic combinations to optimize parasite control in cattle","volume":"53","author":"Canton","year":"2023","journal-title":"Int J. Parasitol."},{"issue":"1-2","key":"10.1016\/j.biopha.2026.119528_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.vetpar.2008.07.014","article-title":"Dose determination studies for monepantel, an amino-acetonitrile derivative, against fourth stage gastro-intestinal nematode larvae infecting sheep","volume":"157","author":"Hosking","year":"2008","journal-title":"Vet. Parasitol."},{"issue":"9","key":"10.1016\/j.biopha.2026.119528_bib5","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.bmcl.2008.03.071","article-title":"Discovery of amino-acetonitrile derivatives, a new class of synthetic anthelmintic compounds","volume":"18","author":"Ducray","year":"2008","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2026.119528_bib6","unstructured":"National Center for Biotechnology Information. PubChem Compound Summary for CID 44449087: Monepantel. PubChem: National Library of Medicine (US); 2025."},{"issue":"7184","key":"10.1016\/j.biopha.2026.119528_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nature06722","article-title":"A new class of anthelmintics effective against drug-resistant nematodes","volume":"452","author":"Kaminsky","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2026.119528_bib8","unstructured":"Australian Pesticides and Veterinary Medicines Authority. Public Release Summary on the Evaluation of the New Active Monepantel in the Product Zolvix Monepantel Broad Spectrum Oral Anthelmintic for Sheep. Canberra (Australia); 2010."},{"key":"10.1016\/j.biopha.2026.119528_bib9","unstructured":"Limited NT. Leiden University Medical Centre \u2013 Monepantel COVID\u201119 Testing: Listcorp; 2021 [Available from: \u3008https:\/\/www.listcorp.com\/asx\/nuz\/neurizon-therapeutics-limited\/news\/leiden-university-medical-centre-monepantel-covid-19-testing-2492958.html.\u3009."},{"issue":"11","key":"10.1016\/j.biopha.2026.119528_bib10","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1016\/j.apsb.2024.08.027","article-title":"Solubilization techniques used for poorly water-soluble drugs","volume":"14","author":"Xie","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.biopha.2026.119528_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2885.2008.01052.x","article-title":"Pharmacokinetics of monepantel and its sulfone metabolite, monepantel sulfone, after intravenous and oral administration in sheep","volume":"32","author":"Karadzovska","year":"2009","journal-title":"J. Vet. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib12","first-page":"4","article-title":"Monepantel (Veterinary Medicinal Products)","volume":"8","year":"2020","journal-title":"Food Saf. (Tokyo)"},{"issue":"5","key":"10.1016\/j.biopha.2026.119528_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/jvp.12296","article-title":"Hepatic biotransformation pathways and ruminal metabolic stability of the novel anthelmintic monepantel in sheep and cattle","volume":"39","author":"Ballent","year":"2016","journal-title":"J. Vet. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.119528_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00280-020-04146-5","article-title":"A preliminary assessment of oral monepantel's tolerability and pharmacokinetics in individuals with treatment-refractory solid tumors","volume":"86","author":"Mislang","year":"2020","journal-title":"Cancer Chemother. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2026.119528_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/dta.1630","article-title":"Metabolic pathways of anthelmintic drug monepantel in sheep and in its parasite (Haemonchus contortus)","volume":"6","author":"Stuchl\u00edkov\u00e1","year":"2014","journal-title":"Drug Test. Anal."},{"issue":"16","key":"10.1016\/j.biopha.2026.119528_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/vr.b4830","article-title":"Effect of route of administration on the efficacy and pharmacokinetics of an experimental formulation of the amino-acetonitrile derivative monepantel in sheep","volume":"166","author":"Hosking","year":"2010","journal-title":"Vet. Rec."},{"issue":"4","key":"10.1016\/j.biopha.2026.119528_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/00480169.2009.36901","article-title":"Safety of an amino-acetonitrile derivative (AAD), monepantel, in ewes and their offspring following repeated oral administration","volume":"57","author":"Malikides","year":"2009","journal-title":"N. Z. Vet. J."},{"key":"10.1016\/j.biopha.2026.119528_bib18","unstructured":"Agency E.M. European public MRL assessment report: Monepantel (caprine and ovine species). Assessment report. London, United Kingdom: Committee for Medicinal Products for Veterinary Use (CVMP), European Medicines Agency; 2012. Report No.: EMA\/CVMP\/165324\/2008."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2307\/3279120","article-title":"Ultrastructural changes in Ascaris suum intestine after mebendazole treatment in vivo","volume":"61","author":"Borgers","year":"1975","journal-title":"J. Parasitol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1090-0233(05)80005-X","article-title":"Modes of action of anthelmintic drugs","volume":"154","author":"Martin","year":"1997","journal-title":"Vet. J."},{"issue":"5","key":"10.1016\/j.biopha.2026.119528_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1124\/mol.110.066498","article-title":"Monepantel allosterically activates DEG-3\/DES-2 channels of the gastrointestinal nematode Haemonchus contortus","volume":"78","author":"Rufener","year":"2010","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2026.119528_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000380","article-title":"Haemonchus contortus acetylcholine receptors of the DEG-3 subfamily and their role in sensitivity to monepantel","volume":"5","author":"Rufener","year":"2009","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.biopha.2026.119528_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001091","article-title":"Phylogenomics of ligand-gated ion channels predicts monepantel effect","volume":"6","author":"Rufener","year":"2010","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1124\/mol.114.095653","article-title":"Monepantel irreversibly binds to and opens Haemonchus contortus MPTL-1 and Caenorhabditis elegans ACR-20 receptors","volume":"87","author":"Baur","year":"2015","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2026.119528_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003524","article-title":"acr-23 Encodes a monepantel-sensitive channel in Caenorhabditis elegans","volume":"9","author":"Rufener","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijpddr.2017.12.001","article-title":"Monepantel is a non-competitive antagonist of nicotinic acetylcholine receptors from Ascaris suum and Oesophagostomum dentatum","volume":"8","author":"Abongwa","year":"2018","journal-title":"Int J. Parasitol. Drugs Drug Resist"},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010312","article-title":"The Caenorhabditis elegans DEG-3\/DES-2 Channel Is a Betaine-Gated Receptor Insensitive to Monepantel","volume":"27","author":"Hansen","year":"2022","journal-title":"Molecules"},{"issue":"17","key":"10.1016\/j.biopha.2026.119528_bib28","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1038\/s44318-024-00165-7","article-title":"Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23","volume":"43","author":"Liu","year":"2024","journal-title":"Embo J."},{"key":"10.1016\/j.biopha.2026.119528_bib29","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s13071-014-0598-z","article-title":"First report of monepantel Haemonchus contortus resistance on sheep farms in Uruguay","volume":"7","author":"Mederos","year":"2014","journal-title":"Parasit. Vectors"},{"issue":"2","key":"10.1016\/j.biopha.2026.119528_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpddr.2015.05.001","article-title":"Selection and characterisation of monepantel resistance in Teladorsagia circumcincta isolates","volume":"5","author":"Bartley","year":"2015","journal-title":"Int J. Parasitol. Drugs Drug Resist"},{"issue":"4","key":"10.1016\/j.biopha.2026.119528_bib31","doi-asserted-by":"crossref","DOI":"10.1590\/s1984-29612025060","article-title":"Using the new guideline for diagnosing anthelmintic resistance of gastrointestinal nematodes to different chemical components in sheep in the Rio Grande do Norte State, Brazil","volume":"34","author":"Lima J\u00fanior","year":"2025","journal-title":"Rev. Bras. Parasitol. Vet."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13071-025-06930-9","article-title":"Old world camels in Germany: parasitic nematode communities characterized by nemabiome analysis showed reduced anthelmintic efficacy according to the fecal egg count reduction test","volume":"18","author":"Brachmann","year":"2025","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.biopha.2026.119528_bib33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ebiom.2016.11.034","article-title":"Parasite Infection, Carcinogenesis and Human Malignancy","volume":"15","author":"van Tong","year":"2017","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.biopha.2026.119528_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006649","article-title":"Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer","volume":"13","author":"Pastille","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2026.119528_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2016.09.006","article-title":"Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis","volume":"20","author":"Moormann","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.biopha.2026.119528_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105207","article-title":"Ivermectin, a potential anticancer drug derived from an antiparasitic drug","volume":"163","author":"Tang","year":"2021","journal-title":"Pharm. Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.114.218644","article-title":"The antiparasitic drug, potassium antimony tartrate, inhibits tumor angiogenesis and tumor growth in nonsmall-cell lung cancer","volume":"352","author":"Wang","year":"2015","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2026.119528_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/756568","article-title":"Vitro Antiparasitic and Apoptotic Effects of Antimony Sulfide Nanoparticles on Leishmania infantum","volume":"2012","author":"Soflaei","year":"2012","journal-title":"J. Parasitol. Res"},{"key":"10.1016\/j.biopha.2026.119528_bib39","article-title":"Repositioning of Antiparasitic Drugs for Tumor Treatment","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol."},{"issue":"14","key":"10.1016\/j.biopha.2026.119528_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144957","article-title":"Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System","volume":"21","author":"Laudisi","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.biopha.2026.119528_bib41","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2217\/fon.14.65","article-title":"Mutual Action of Anticancer and Antiparasitic Drugs: Are there any Shared Targets?","volume":"10","author":"Dorosti","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.biopha.2026.119528_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2407-10-143","article-title":"Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole","volume":"10","author":"Pourgholami","year":"2010","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2026.119528_bib43","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1158\/1078-0432.CCR-05-1181","article-title":"Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice","volume":"12","author":"Pourgholami","year":"2006","journal-title":"Clinical cancer research official journal American Association Cancer Research"},{"issue":"4","key":"10.1016\/j.biopha.2026.119528_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbrc.2010.06.019","article-title":"Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis","volume":"397","author":"Pourgholami","year":"2010","journal-title":"Biochem Biophys. Res Commun."},{"issue":"10","key":"10.1016\/j.biopha.2026.119528_bib45","first-page":"3791","article-title":"Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole","volume":"29","author":"Chu","year":"2009","journal-title":"Anticancer Res"},{"issue":"42","key":"10.1016\/j.biopha.2026.119528_bib46","doi-asserted-by":"crossref","first-page":"68571","DOI":"10.18632\/oncotarget.11851","article-title":"Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model","volume":"7","author":"Williamson","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.biopha.2026.119528_bib47","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00432-013-1539-5","article-title":"Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer","volume":"139","author":"Nygren","year":"2013","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55666-x","article-title":"Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma","volume":"9","author":"Younis","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2026.119528_bib49","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2147\/DDDT.S172538","article-title":"Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth","volume":"12","author":"Gallardo","year":"2018","journal-title":"Drug Des. Devel Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib50","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12917-019-2026-2","article-title":"Ivermectin inhibits canine mammary tumor growth by regulating cell cycle progression and WNT signaling","volume":"15","author":"Diao","year":"2019","journal-title":"BMC Vet. Res"},{"issue":"16_","key":"10.1016\/j.biopha.2026.119528_bib51","article-title":"A phase I\/II study evaluating the safety and efficacy of ivermectin in combination with balstilimab in patients with metastatic triple negative breast cancer","volume":"43","author":"Yuan","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2026.119528_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120536","article-title":"Mebendazole; from an anti-parasitic drug to a promising candidate for drug repurposing in colorectal cancer","volume":"299","author":"Hegazy","year":"2022","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.119528_bib53","first-page":"545","article-title":"Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer","volume":"4","author":"Bahrami","year":"2014","journal-title":"Am. J. Cancer Res"},{"issue":"11","key":"10.1016\/j.biopha.2026.119528_bib54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1751-0813.2009.00511.x","article-title":"Clinical field study to evaluate the efficacy and safety of the amino-acetonitrile derivative, monepantel, compared with registered anthelmintics against gastrointestinal nematodes of sheep in Australia","volume":"87","author":"Hosking","year":"2009","journal-title":"Aust. Vet. J."},{"issue":"5","key":"10.1016\/j.biopha.2026.119528_bib55","first-page":"558","article-title":"Monepantel induces autophagy in human ovarian cancer cells through disruption of the mTOR\/p70S6K signalling pathway","volume":"4","author":"Bahrami","year":"2014","journal-title":"Am. J. Cancer Res"},{"issue":"6","key":"10.1016\/j.biopha.2026.119528_bib56","first-page":"3098","article-title":"Monepantel antitumor activity is mediated through inhibition of major cell cycle and tumor growth signaling pathways","volume":"11","author":"Bahrami","year":"2021","journal-title":"Am. J. Cancer Res"},{"issue":"10","key":"10.1016\/j.biopha.2026.119528_bib57","first-page":"2064","article-title":"Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies","volume":"8","author":"Ataie-Kachoie","year":"2018","journal-title":"Am. J. Cancer Res"},{"issue":"12","key":"10.1016\/j.biopha.2026.119528_bib58","doi-asserted-by":"crossref","first-page":"13522","DOI":"10.1002\/cam4.6021","article-title":"Induction of endoplasmic reticulum stress is associated with the anti-tumor activity of monepantel across cancer types","volume":"12","author":"Harris","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.biopha.2026.119528_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1665272","article-title":"ER stress sensors at the ER-mitochondrial interface, controlling mitochondrial health in neurodegenerative diseases","volume":"19","author":"Kunja","year":"2025","journal-title":"Front Neurosci."},{"key":"10.1016\/j.biopha.2026.119528_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157288","article-title":"Astragaloside VI attenuates mechanical stress-induced cardiac remodeling through piezo1-VDAC1 dependent endoplasmic reticulum unfolded protein response","volume":"148","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"issue":"14","key":"10.1016\/j.biopha.2026.119528_bib61","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.7150\/ijbs.102424","article-title":"Targeting mitochondria by lipid-selenium conjugate drug results in malate\/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression","volume":"20","author":"Chang","year":"2024","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.biopha.2026.119528_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1422686","article-title":"Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality","volume":"15","author":"Pang","year":"2024","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2026.119528_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118237","article-title":"The mTOR pathway in Gliomas: From molecular insights to targeted therapies","volume":"189","author":"Pournajaf","year":"2025","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib64","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12035-025-05653-3","article-title":"The mTOR Pathway in Hearing Disorders: Mechanistic Links to Aging, Regeneration, and Neurodegeneration","volume":"63","author":"Pournajaf","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2026.119528_bib65","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3389\/fonc.2019.01373","article-title":"mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer","volume":"9","author":"de la Cruz L\u00f3pez","year":"2019","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.biopha.2026.119528_bib66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jgr.2025.04.006","article-title":"Ginsenoside Rb1 attenuates coronary microvascular inflammatory injury via NDUFS4-SIRT5-DUSP1-mediated mitochondrial quality control in a murine ischemia-reperfusion model","volume":"49","author":"Pu","year":"2025","journal-title":"J. Ginseng Res"},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib67","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12951-025-03420-z","article-title":"Ligustrazine nano-drug delivery system ameliorates doxorubicin-mediated myocardial injury via piezo-type mechanosensitive ion channel component 1-prohibitin 2-mediated mitochondrial quality surveillance","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.biopha.2026.119528_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/19768354.2023.2181217","article-title":"Crosstalk between endoplasmic reticulum stress response and autophagy in human diseases","volume":"27","author":"Kwon","year":"2023","journal-title":"Anim. Cells Syst. (Seoul. )"},{"issue":"5","key":"10.1016\/j.biopha.2026.119528_bib69","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nri2546","article-title":"Immunoregulatory functions of mTOR inhibition","volume":"9","author":"Thomson","year":"2009","journal-title":"Nat. Rev. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226005640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T23:00:12Z","timestamp":1787439612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226005640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":69,"alternative-id":["S0753332226005640"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119528","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing monepantel in oncology: A conceptual mini-review of proposed mechanisms","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119528"}}